This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wockhardt Limited. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Jaykumar Satwaji Satav: Innovator in Pharmaceutical Compositions
Introduction
Jaykumar Satwaji Satav is a notable inventor based in Hingoli, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Jaykumar Satwaji Satav holds a patent for "Pharmaceutical compositions comprising antibacterial agents." This patent discloses a pharmaceutical composition that includes a carbapenem antibacterial agent selected from imipenem, meropenem, ertapenem, doripenem, or a pharmaceutically acceptable derivative thereof. Additionally, it features a compound of Formula (I), or a stereoisomer or a pharmaceutical acceptable derivative thereof. This patent highlights his commitment to advancing medical treatments and addressing bacterial infections.
Career Highlights
Jaykumar is currently employed at Wockhardt Limited, a prominent pharmaceutical company known for its innovative healthcare solutions. His role at Wockhardt Limited allows him to collaborate with other talented professionals in the industry, further enhancing his contributions to pharmaceutical research and development.
Collaborations
Some of his coworkers include Mahesh Vithalbhai Patel and Sachin Subhash Bhagwat. Their collaboration fosters a creative environment that encourages the exchange of ideas and expertise, ultimately leading to groundbreaking advancements in the pharmaceutical sector.
Conclusion
Jaykumar Satwaji Satav's work in pharmaceutical compositions exemplifies the impact of innovation in healthcare. His patent for antibacterial agents is a testament to his dedication to improving medical treatments. Through his career at Wockhardt Limited, he continues to contribute to the advancement of pharmaceuticals, making a significant difference in the industry.